Matinas Biopharma Holdings, Inc. · AMEX:MTNB
Stern Adam K exercised options for 1,067,145 Matinas Biopharma Holdings, Inc. shares (Form 4)
Traded Oct 31, 2025 to Jul 10, 2026 · Filed Aug 13, 2026
From Oct 31, 2025 to Jul 10, 2026, Stern Adam K (10% owner) exercised options for 1,067,145 Matinas Biopharma Holdings, Inc. shares at an average US$0.38 for US$400K, leaving 743,785 shares. Filed Aug 13, 2026 (Form 4).
- Options exercised
- 1,067,145 shares
- Price
- US$0.38 average (US$0.35 to US$0.64)
- Value
- US$400K
- Holding after
- 743,785 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 31, 2025 | Common Stock, par value $0.0001 per share | Option exercise | 92,100 | US$0.64 | 113,450 | Indirect |
| Jul 10, 2026 | Common Stock, par value $0.0001 per share | Option exercise | 344,710 | US$0.35 | 416,900 | Indirect |
| Jul 10, 2026 | Common Stock, par value $0.0001 per share | Option exercise | 630,335 | US$0.35 | 743,785 | Indirect |
Source
Related
- Matinas Biopharma Holdings, Inc.
- Stern Adam K
- Matinas Biopharma Holdings, Inc. shareholders
- Schedule 13D/A · Stern Adam K · Aug 13, 2026
- Schedule 13G · Hezbay Holdings LLC · Jul 14, 2026
- Schedule 13G/A · Highbridge Capital Management LLC · Nov 14, 2025
- Schedule 13D/A · Hezbay Holdings LLC · Sep 25, 2025
- Schedule 13G · Lazar David E. · Aug 19, 2025